Andrew Phillips
Listed on 7 Form D filings across 3+ issuers
· Director, Executive Officer
Associated issuers
- LiquidX, Inc. CIK 1759495 · NY
- Nexo Therapeutics, Inc. CIK 1955319 · CO
- Kestrel Therapeutics Inc. CIK 1853373 · MA
Filings (7)
-
LiquidX, Inc.D · Apr 30, 2026 · NY · Other Technology$5.7MView filing →
-
Nexo Therapeutics, Inc.D · Mar 27, 2026 · CO · Biotechnology$60MView filing →
-
LiquidX, Inc.D · Oct 21, 2025 · NY · Other Technology$3.9MView filing →
-
Nexo Therapeutics, Inc.D · Sep 17, 2025 · CO · Biotechnology$60MView filing →
-
Kestrel Therapeutics Inc.D · Aug 12, 2025 · MA · Biotechnology$10MView filing →
-
LiquidX, Inc.D · Apr 9, 2025 · NY · Other Technology$2.5MView filing →
-
Kestrel Therapeutics Inc.D · Feb 21, 2025 · MA · Biotechnology$16MView filing →